Tumor progression of type 2 pRCC is more dependent on fumarate accumulation and HIF‐1α/2α activation due to FH deletion.[43] MET, a receptor tyrosine kinase, is typically inactive in the absence of its ligand, hepatocyte growth factor (HGF). Here, HGF is linked to neoplasm.